Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BioHarvest Sciences ( (BHST) ) has issued an update.
BioHarvest Sciences Inc. has launched the VINIA® DailyChews 2X Formula, a chew designed to enhance blood flow and oxygen delivery for athletes and active individuals. This product, which features a double dose of the company’s proprietary red grape cell composition, is Informed Sport-certified, ensuring safety and efficacy for professional athletes and fitness enthusiasts. The launch marks BioHarvest’s expansion into the athlete and fitness segment of the nutraceuticals market, supported by a new international ecommerce platform that facilitates global orders.
The most recent analyst rating on (BHST) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on BioHarvest Sciences stock, see the BHST Stock Forecast page.
More about BioHarvest Sciences
BioHarvest Sciences Inc. is a leader in Botanical Synthesis, utilizing its patented technology platform to grow plant-based compounds without cultivating the actual plant. The company operates in two main business verticals: as a contract development and manufacturing organization (CDMO) for novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products, including dietary supplements.
Average Trading Volume: 23,591
Technical Sentiment Signal: Buy
Current Market Cap: $100.5M
For detailed information about BHST stock, go to TipRanks’ Stock Analysis page.